🌐 EN ▾
  • EN - English
  • FR - French
  • DE - German
  • JP - Japanese
  • KR - Korean
PEA Support

Liposomal
Palmitoylethanolamide (PEA)

Advanced Delivery for Superior Neuro & Joint Support

Palmitoylethanolamide (PEA) is a naturally occurring compound found in the body, known to support cellular health, nerve, joint comfort and natural physiological balance. It is widely valued for its role in promoting wellness, maintaining the body's natural response to daily stresses, and supporting overall vitality.

The Bioavailability Limitations

Nerve Icon

Variable Absorption

Only a small fraction is absorbed.

Nerve Icon

Delayed Onset

Effects may take longer without advanced delivery systems.

Nerve Icon

Digestive Sensitivity

High doses may cause mild gastrointestinal issues.

Nerve Icon

Short Duration

Requires repeated intake to maintain levels.

The Liposomal Advantage

Liposomal PEA, powered by LipsoBio®'s patent filed DFS Technology™, uses advanced liposomal encapsulation to protect PEA during digestion. This enhanced delivery system improves absorption and bioavailability, supporting faster relief, promoting neurological wellness, cellular health,and overall comfort. It helps maintain a balanced inflammatory response, supports joint and nerve health, and contributes to overall vitality and wellbeing.

Grade/Specification Available Form
Liposomal Palmitoylethanolamide 30% Powder

Backed by Science, Proven in Research

  • Cellular Uptake Study (Caco-2 model): Liposomal PEA demonstrated 1.8-fold higher membrane permeability compared to Non- Liposomal PEA, confirming improved absorption.
  • Analytical Validation: TEM, zeta potenal and parcle size measurements confirm uniform, stable liposomes for reliable quality and nutrient delivery.

Liposomal PEA Benefits

Promotes nerve
function

Nerve Icon

Aids joint and
muscle wellbeing

Joint Icon

Helps manage stress and supports mental clarity

Mental Icon

Why Liposomal PEA is Superior?

Feature
Liposomal PEA
Conventional PEA
Absorption Technology
DFS Technology™ – advanced liposomal delivery
Basic form – poor absorption
Bioavailability
Maximized absorption of Palmitoylethanolamide for faster and more consistent effect
Low, limited by degradation in the digestive tract
Stability & Efficacy
Protected from degradation, stable & potent
Unstable, prone to digestive loss
Analytical Validation
TEM, Zeta, PDI advanced validation
No advanced validation
Tolerance
Gentle and effective delivery
May require higher doses, with potential tolerance issues

Backed by External Peer-Reviewed Research

Springer Nature | Inflammopharmacology

STUDY YEAR | 2022 | Emily Pickering et al.

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating ...

READ THE STUDY

MDPI | Nutrients

STUDY YEAR | 2022 | Kordula Lang-Illievich et al.

The effect of palmitoylethanolamide on pain intensity, central and peripheral sensitization ...

READ THE STUDY

Springer Nature | Inflammopharmacology

STUDY YEAR | 2019 | Elizabeth Steels et al.

A double-blind, randomized, placebo-controlled study assessing safety, tolerability, and efficacy ...

READ THE STUDY

Elsevier | Journal of Affective Disorders

STUDY YEAR | 2018 | Maryam Ghazizadeh-Hashemi et al.

Palmitoylethanolamide as adjunctive therapy in major depressive disorder: a double-blind study ...

READ THE STUDY

Š 2026 LipsoBioŽ All Rights Reserved.

Disclaimer -

Please note that this website and the information provided are not intended for end consumers of finished food, beverage, dietary supplement, or cosmetic products, as the content here does not pertain to consumer-ready finished products. The statements related to ingredients on the website has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. By continuing to browse, you acknowledge and accept the terms outlined above.

top